A prospective randomized open-label crossover trial of regional citrate anticoagulation vs. anticoagulation free liver dialysis by the Molecular Adsorbents Recirculating System

Critical Care

Volumn 16, Issue 1, 2012, Pages

  Meijers, Björn ^a   Laleman, Wim ^a   Vermeersch, Pieter ^a   Nevens, Frederik ^a   Wilmer, Alexander ^a   Evenepoel, Pieter ^a  

^a UNIVERSITY HOSPITALS LEUVEN   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

CITRIC ACID; ANTICOAGULANT AGENT;

ADULT; AGED; ANTICOAGULANT THERAPY; ARTICLE; BLEEDING; CLINICAL ARTICLE; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; CROSSOVER PROCEDURE; DIALYSIS; HUMAN; INTERMETHOD COMPARISON; LIVER FAILURE; MOLECULAR ADSORBENT RECYCLING SYSTEM; OPEN STUDY; PATIENT SAFETY; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME; TREATMENT WITHDRAWAL; ADSORPTION; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; DRUG EFFECT; EXTRACORPOREAL CIRCULATION; METHODOLOGY; MIDDLE AGED; PHYSIOLOGY;

ADSORPTION; ADULT; AGED; ANTICOAGULANTS; CITRIC ACID; CROSS-OVER STUDIES; EXTRACORPOREAL CIRCULATION; HUMANS; LIVER FAILURE; MIDDLE AGED; PROSPECTIVE STUDIES;

EID: 84856439557     PISSN: 13648535     EISSN: 1466609X     Source Type: Journal    
DOI: 10.1186/cc11180     Document Type: Article

References (20)

1. Laleman W, Verbeke L, Meersseman P, Wauters J, van Pelt J, Cassiman D, Wilmer A, Verslype C, Nevens F. Acute-on-chronic liver failure: current concepts on definition, pathogenesis, clinical manifestations and potential therapeutic interventions. Expert Rev Gastroenterol Hepatol 2011, 5:523-537. 10.1586/egh.11.47, 21780899.
2. Laleman W, Wilmer A, Evenepoel P, Verslype C, Fevery J, Nevens F. Review article: non-biological liver support in liver failure. Aliment Pharmacol Ther 2006, 23:351-363. 10.1111/j.1365-2036.2006.02765.x, 16422994.
3. Tripodi A, Mannucci PM. The coagulopathy of chronic liver disease. N Engl J Med 2011, 365:147-156. 10.1056/NEJMra1011170, 21751907.
4. Meijers BKI, Verhamme P, Nevens F, Hoylaerts MF, Bammens B, Wilmer A, Arnout J, Vanrenterghem Y, Evenepoel P. Major coagulation disturbances during fractionated plasma separation and adsorption. Am J Transplant 2007, 7:2195-2199. 10.1111/j.1600-6143.2007.01909.x, 17640311.
5. Faybik P, Bacher A, Kozek-Langenecker SA, Steltzer A, Krenn CG, Unger S, Hetz H. Molecular adsorbent recirculating system and hemostasis in patients at high risk of bleeding: an observational study. Crit Care 2006, 10:R24. 10.1186/cc3985, 1550822, 16469128.
6. Doria C, Mandala L, Smith JD, Caruana G, Scott VL, Gruttadauria S, Magnone M, Marino IR. Thromboelastography used to assess coagulation during treatment with molecular adsorbent recirculating system. Clin Transplant 2004, 18:365-371. 10.1111/j.1399-0012.2004.00172.x, 15233811.
7. Bachli EB, Schuepbach RA, Maggiorini M, Stocker R, Mullhaupt B, Renner EL. Artificial liver support with the molecular adsorbent recirculating system: activation of coagulation and bleeding complications. Liver Int 2007, 27:475-484. 10.1111/j.1478-3231.2006.01398.x, 17403187.
8. Tan HK, Yang WS, Chow P, Lui HF, Choong HL, Wong KS. Anticoagulation minimization is safe and effective in albumin liver dialysis using the molecular adsorbent recirculating system. Artif Organs 2007, 31:193-199. 10.1111/j.1525-1594.2007.00364.x, 17343694.
9. Yang WS, Tan HK, Lui HF, Chow PK, Choong HL, Wong KS. Albumin dialysis in critically ill patients: use versus omission of intradialytic heparin. Artif Organs 2008, 32:411-416. 10.1111/j.1525-1594.2008.00560.x, 18471171.
10. Tan HK, Yang WS, Choong HL, Wong KS. Albumin Dialysis Without Anticoagulation in High-Risk Patients: An Observational Study. Artif Organs 2010, doi: 10.1111/j.1525-1594.2010.01065.x.
11. Evenepoel P, Maes B, Vanwalleghem J, Kuypers D, Messiaen T, Vanrenterghem Y. Regional citrate anticoagulation for hemodialysis using a conventional calcium-containing dialysate. Am J Kidney Dis 2002, 39:315-323. 10.1053/ajkd.2002.30551, 11840372.
12. Hofbauer R, Moser D, Frass M, Oberbauer R, Kaye AD, Wagner O, Kapiotis S, Druml W. Effect of anticoagulation on blood membrane interactions during hemodialysis. kidney int 1999, 56:1578-1583. 10.1046/j.1523-1755.1999.00671.x, 10504511.
13. Kramer L, Bauer E, Joukhadar C, Strobl W, Gendo A, Madl C, Gangl A. Citrate pharmacokinetics and metabolism in cirrhotic and noncirrhotic critically ill patients. Crit Care Med 2003, 31:2450-2455. 10.1097/01.CCM.0000084871.76568.E6, 14530750.
14. Herget-Rosenthal S, Lison C, Treichel U, Saner S, Pietruck F, Broelsch C, Gerken G, Kribben A. Citrate anticoagulated modified fractionated plasma separation and adsoprtion: First clinical efficacy and safety data in liver failure. J Am Soc Nephrol 2003, 14:729A.
15. Faybik P, Hetz H, Mitterer G, Krenn CG, Schiefer J, Funk GC, Bacher A. Regional citrate anticoagulation in patients with liver failure supported by a molecular adsorbent recirculating system. Crit Care Med 2011, 39:273-279. 10.1097/CCM.0b013e3181fee8a4, 20975551.
16. Morgera S. Regional anticoagulation with citrate: expanding its indications. Crit Care Med 2011, 39:399-400. 10.1097/CCM.0b013e318205c500, 21248519.
17. Gines P, Quintero E, Arroyo V, Teres J, Bruguera M, Rimola A, Caballería J, Rodés J, Rozman C. Compensated cirrhosis: natural history and prognostic factors. Hepatology 1987, 7:122-128. 10.1002/hep.1840070124, 3804191.
18. Katoonizadeh A, Laleman W, Verslype C, Wilmer A, Maleux G, Roskams T, Nevens F. Early features of acute-on-chronic alcoholic liver failure: a prospective cohort study. Gut 2010, 59:1561-1569. 10.1136/gut.2009.189639, 20675694.
19. Mitzner SR, Stange J, Klammt S, Peszynski P, Schmidt R, Nöldge-Schomburg G. Extracorporeal detoxification using the molecular adsorbent recirculating system for critically ill patients with liver failure. J Am Soc Nephrol 2001, 12:S75-S82.
20. Krisper P, Stauber RE. Technology insight: artificial extracorporeal liver support--how does Prometheus compare with MARS?. Nat Clin Pract Nephrol 2007, 3:267-276. 10.1038/ncpneph0466, 17457360.